To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Bill: 114-hr-5122
Sponsor: full_name: Rep. Bucshon, Larry [R-IN-8]
Introduced: 2016-04-29
Policy area: Health
Subjects: Administrative law and regulatory procedures

Department of Health and Human Services

Drug therapy

Medicare

Prescription drugs
Latest action: action_date: 2016-05-12
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2016-04-29
action_desc: Introduced in House
text: <p>This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).</p>

tv_txt: I 114th CONGRESS 2d Session H. R. 5122 IN THE HOUSE OF REPRESENTATIVES April 29, 2016 Mr. Bucshon (for himself, Mr. Dold , Mr. Boustany , Mr. Tom Price of Georgia , and Mr. Shimkus ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

1. Prohibition of further action on proposed rule regarding testing of Medicare part B prescription drug models The Secretary of Health and Human Services may not take any action to finalize, implement, or enforce the proposed rule entitled Medicare Program; Part B Drug Payment Model (81 Fed. Reg. 13230 (March 11, 2016)).